Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$836M |
| 2 |
Microsoft
MSFT
|
+$748M |
| 3 |
Cigna
CI
|
+$560M |
| 4 |
3M
MMM
|
+$558M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$568M |
| 2 |
Zoom
ZM
|
+$557M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$516M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$479M |
| 5 |
Unity
U
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.72% |
| 2 | Healthcare | 11.35% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Communication Services | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ASTR
5551
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $187K | ﹤0.01% |
20,343
-54,694
| -73% | -$923K |
|
|
SBDS
5552
DELISTED
Solo Brands Inc
SBDS
| $187K | ﹤0.01% |
1,227
-653
| -35% | -$122K |
|
|
ASXC
5553
DELISTED
Asensus Surgical, Inc.
ASXC
| $186K | ﹤0.01% |
414,832
-240,350
| -37% | -$125K |
|
5554
Xeris Biopharma Holdings
XERS
$1.57B
| $185K | ﹤0.01% |
117,570
-9,641
| -8% | -$15.9K |
|
5555
Ituran Location and Control
ITRN
$1.06B
| $184K | ﹤0.01% |
7,920
-975
| -11% | -$24.3K |
|
|
IMA
5556
ImageneBio Inc
IMA
$66.3M
| $183K | ﹤0.01% |
4,293
-1,966
| -31% | -$114K |
|
5557
WisdomTree Yield Enhanced US Short-Term Aggregate Bond Fund
SHAG
$47.3M
| $183K | ﹤0.01% |
3,964
-1,310
| -25% | -$62.1K |
|
5558
Usio Inc
USIO
$76.2M
| $183K | ﹤0.01% |
141,134
+9,057
| +7% | +$16.6K |
|
5559
Arq
ARQ
$102M
| $183K | ﹤0.01% |
66,800
-48,048
| -42% | -$203K |
|
|
VTRU
5560
DELISTED
Vitru Limited Common Shares
VTRU
| $183K | ﹤0.01% |
8,705
-2,684
| -24% | -$47.1K |
|
5561
Century Therapeutics
IPSC
$348M
| $182K | ﹤0.01% |
18,412
-392,373
| -96% | -$4.13M |
|
|
OGCP
5562
Empire State Realty Series 60
OGCP
$1.32B
| $182K | ﹤0.01% |
29,822
| – | – |
|
|
FLC
5563
Flaherty & Crumrine Total Return Fund
FLC
$176M
| $181K | ﹤0.01% |
11,565
-2,249
| -16% | -$39.9K |
|
5564
IBEX
IBEX
$480M
| $181K | ﹤0.01% |
9,737
+8,000
| +461% | +$140K |
|
5565
Microbot Medical
MBOT
$104M
| $181K | ﹤0.01% |
37,888
| – | – |
|
5566
Wrap Technologies
WRAP
$105M
| $181K | ﹤0.01% |
105,826
-35,645
| -25% | -$68.2K |
|
|
HLTH
5567
DELISTED
Cue Health Inc. Common Stock
HLTH
| $181K | ﹤0.01% |
60,109
-25,156
| -30% | -$89.2K |
|
5568
Security National Financial
SNFCA
$242M
| $180K | ﹤0.01% |
34,519
+973
| +3% | +$6.01K |
|
|
ITI
5569
DELISTED
Iteris, Inc.
ITI
| $180K | ﹤0.01% |
60,454
-257,550
| -81% | -$770K |
|
5570
Citius Pharmaceuticals
CTXR
$20.7M
| $179K | ﹤0.01% |
5,940
-2,370
| -29% | -$65.1K |
|
5571
Flexsteel Industries
FLXS
$301M
| $179K | ﹤0.01% |
11,379
-18,570
| -62% | -$324K |
|
|
RBOT
5572
DELISTED
Vicarious Surgical
RBOT
| $179K | ﹤0.01% |
1,776
+1,189
| +203% | +$139K |
|
5573
Direxion Daily FTSE China Bull 3X ETF
YINN
$653M
| $179K | ﹤0.01% |
4,413
+1,102
| +33% | +$73.6K |
|
5574
Arqit Quantum
ARQQ
$424M
| $178K | ﹤0.01% |
1,262
-2,010
| -61% | -$309K |
|
5575
Legacy Housing
LEGH
$698M
| $178K | ﹤0.01% |
10,376
-6,326
| -38% | -$100K |
|
Similar funds
Morgan Stanley's Q3 2022 Portfolio in Review
As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
- Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
- Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
- Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
- Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
- Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.